Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases

doi:10.3748/wjg.v20.i38.14018

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 38

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11726)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

887

WORD

315

HTML

7789

Figures (1-3)

167

Tables (1-3)

213

Sum=9371

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1196

Download

1159

Sum=2355

Oct 14, 2014 (publication date) through Jul 19, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Gastroenterol. Oct 14, 2014; 20(38): 14018-14032
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.14018

Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases

Reza Mirnezami, Brendan J Moran, Kate Harvey, Tom Cecil, Kandiah Chandrakumaran, Norman Carr, Faheez Mohamed, Alexander H Mirnezami

Reza Mirnezami, Section of Biosurgery and Surgical Technology, Department of Surgery and Cancer, Imperial College London, 10^th Floor QEQM Building, St Mary’s Hospital, London W2 1NY, United Kingdom

Brendan J Moran, Kate Harvey, Tom Cecil, Kandiah Chandrakumaran, Faheez Mohamed, National Pseudomyxoma Peritonei Centre, Hampshire Hospitals Foundation Trust, Basingstoke RG24 9NA, United Kingdom

Norman Carr, Alexander H Mirnezami, Somers Cancer Research Building, University of Southampton Cancer Sciences Division, Southampton University Hospital NHS Trust, Southampton SO166YD, United Kingdom

Author contributions: Mirnezami R, Moran BJ, Mohamed F and Mirnezami AH contributed to study conception, literature search and manuscript preparation; Harvey K prepared the manuscript; Cecil T, Chandrakumaran K and Carr N prepared and edited the manuscript.

Supported by Cancer Research United Kingdom; Wessex Medical Research

Correspondence to: Dr. Alexander H Mirnezami, Somers Cancer Research Building, University of Southampton Cancer Sciences Division, Southampton University Hospital NHS Trust, Tremona Road, Southampton SO166YD, United Kingdom. ahm@soton.ac.uk

Telephone: +44-2380-795170 Fax: +44-2380-794020

Received: September 29, 2013
Revised: December 16, 2013
Accepted: June 26, 2014
Published online: October 14, 2014
Processing time: 382 Days and 9.2 Hours

Core Tip

Core tip: Colorectal cancer peritoneal metastases (CPM) confer a dismal prognosis and traditional treatment involving systemic chemotherapy, with or without palliative surgery has poor outcomes. Cytoreductive surgery (CRS) combined with intraperitoneal chemotherapy (IPC) is now advocated for selected patients with CPM. The present study provides a comprehensive summary of the available evidence relating to CRS in combination with IPC in the setting of CPM, focusing on techniques, oncological outcomes, and complications.